跳至主要内容
临床试验/NCT00970918
NCT00970918已完成不适用

Prevalence of Atherosclerotic Disease in Asian Subjects Not on Lipid-lowering Agents, But With at Least Two CVD Risk Factors

AstraZeneca19 个研究点 分布在 9 个国家目标入组 2,609 人开始时间: 2009年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
2,609
试验地点
19
主要终点
Measurement of Carotid Intima Media Thickness of people with high risk of cardiovascular disease but not on lipid lowering drugs

研究概览

简要总结

The purpose of this study is to obtain the distribution of measurements of the intima media thickness of carotid arteries in people with high cardiovascular risk.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening

入排标准

年龄范围
30 Years 至 69 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Provision of signed informed consent.
  • Patients with at least two CVD risk factors but not on lipid-lowering agents

排除标准

  • Subjects with CHD, any conditions that may affect hs-CRP levels.
  • Subjects on any lipid-lowering drug treatment within the last 3 months prior study entry.

结局指标

主要结局

Measurement of Carotid Intima Media Thickness of people with high risk of cardiovascular disease but not on lipid lowering drugs

时间窗: IIMT measurements taken only once, either on Visit 1 or Visit 2 (time gap between V1 and V2 should be less than 3 months)

次要结局

  • Lipid profile of people with high risk of cardiovascular disease but not on lipid lowering drugs(Blood sampling only once, either on Visit 1 or Visit 2 (time gap between V1 and V2 should be less than 3 months))

研究者

发起方
AstraZeneca
申办方类型
Industry

研究点 (19)

Loading locations...

相似试验